Dr Narinder Kaur, PHARMD, BCPS in Denver, CA - Pharmacist

Dr Narinder Kaur, PHARMD, BCPS is a Pharmacist based in Denver, California. Dr Narinder Kaur is licensed to practice in Michigan (license number 5302041931) and her current practice location is 1055 Clermont St, Pharmacy Service (119), Denver, California. She can be reached at her office (for appointments etc.) via phone at (303) 399-8020.

NPI number for Dr Narinder Kaur is 1326559006 and her current mailing address is 1055 Clermont St, Pharmacy Service (119), Denver, Colorado. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1326559006.

Contact Information

	Dr Narinder Kaur, PHARMD, BCPS
	1055 Clermont St, Pharmacy Service (119), Denver, CA 80220
	(303) 399-8020
	Not Available

Healthcare Provider's Profile

Full Name	Dr Narinder Kaur
Gender	Female
Speciality	Pharmacist
Location	1055 Clermont St, Denver, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1326559006
Provider Enumeration Date: 10/20/2017
Last Update Date: 10/20/2017

Medical Identifiers

Medical identifiers for Dr Narinder Kaur such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1326559006	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PHA.0021724 (Colorado)	Secondary
183500000X	Pharmacist	28RI03826300 (New Jersey)	Secondary
183500000X	Pharmacist	059779 (New York)	Secondary
183500000X	Pharmacist	5302041931 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Narinder Kaur is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Narinder Kaur, PHARMD, BCPS 1055 Clermont St, Pharmacy Service (119), Denver, CO 80220 Ph: (303) 399-8020	Dr Narinder Kaur, PHARMD, BCPS 1055 Clermont St, Pharmacy Service (119), Denver, CA 80220 Ph: (303) 399-8020

News Archive

Choosing better treatment for ankle fractures

Many people associate ankle fractures with sports, but you don't have to be an athlete to develop a serious ankle injury. Ankle fractures, in which there is a partial or complete break in a bone, can happen to anyone. People can break an ankle after a fall, car accident or twisting injury.

DARA Therapeutics collaborates to advance clinical study of KRN5500 for CIPN in cancer patients

DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.

Patients with hypertension or diabetes have increased risk of cancer recurrence, survival

By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and Fox Chase Cancer Center has shown just how deadly this mix can be.

RT after surgery could reduce chances of local DCIS recurrence by 50%

Radiotherapy treatment (RT) after surgery for ductal carcinoma in situ (DCIS) still has a major protective effect against recurrence more than 15 years later, according to the results of an international trial.

Researchers discover new hybrid molecules that could act as anti-cancer agents

Researchers from NYU Abu Dhabi's chemistry program and colleagues from the University's biology program have developed and studied the biological activity of five new, metal-organic hybrid knotted molecules, termed metal-organic trefoil knots.

Dr Narinder Kaur, PHARMD, BCPS - Pharmacist in Denver, CA